NHS to start using the steroid hydrocortisone on Covid-19 patients as it boost survival by up to 93%

Patients given the drug for seven days were compared to those who were not. They had a 93 per cent better recovery odds - measured by either a greater chance or survival or less need for organ support such as ventilation. The findings come from the REMAP-CAP trial involving hospitals globally. NHS chief executive Sir Simon Stevens said the NHS will 'now take immediate action to ensure that patients who could benefit from hydrocortisone do so.' Another study published today found three steroids reduce risk of death by 20%